Rudkowski Z, Bromirska J
Klinik für infektiöse Kinderkrankheiten, Medizinischen Akademie Wroclaw, Polen.
Padiatr Padol. 1991;26(2):111-4.
Salmonella-enteritis is known to be an infectious disease of world-wide epidemiologic importance. The treatment of chronic carriers of pathogenic salmonella has shown to be a major therapeutic problem. In a controlled clinical study the efficiency of Hylak forte (containing products of metabolism of symbiotic bacteria) in the management of salmonellosis in infants was investigated. In patients receiving Hylak forte the period of faecal excretion of salmonella was significantly (p = 0.0022) shortened in comparison with the control-group. No side-effects did occur. Hylak forte proved to be effective in the therapy of enteritis in infants; the period of excretion of salmonella was significantly reduced.
肠炎沙门氏菌是一种具有全球流行病学重要性的传染病。致病性沙门氏菌慢性携带者的治疗已被证明是一个主要的治疗难题。在一项对照临床研究中,研究了Hylak forte(含有共生细菌代谢产物)治疗婴儿沙门氏菌病的疗效。与对照组相比,接受Hylak forte治疗的患者沙门氏菌粪便排泄期显著缩短(p = 0.0022)。未出现副作用。Hylak forte被证明对婴儿肠炎治疗有效;沙门氏菌排泄期显著缩短。